Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Update

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a decrease of 98.6% from the October 31st total of 7,100 shares. Based on an average daily volume of 44,400 shares, the short-interest ratio is presently 0.0 days.

Awakn Life Sciences Price Performance

AWKNF traded up $0.01 on Wednesday, hitting $0.09. 3,119 shares of the company’s stock were exchanged, compared to its average volume of 15,564. The stock has a fifty day moving average of $0.08 and a two-hundred day moving average of $0.09. Awakn Life Sciences has a twelve month low of $0.05 and a twelve month high of $0.19.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.